Edition:
United Kingdom

People: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

560.00INR
8:04am BST
Change (% chg)

Rs1.00 (+0.18%)
Prev Close
Rs559.00
Open
Rs560.00
Day's High
Rs564.80
Day's Low
Rs556.50
Volume
282,229
Avg. Vol
604,820
52-wk High
Rs711.90
52-wk Low
Rs505.50

Pinto, Cherylann 

Mrs. Cherylann (Cheryl) Pinto is Director - Corporate Affairs, Executive Director of the Company. Mrs. Pinto is the Director of Corporate Affairs at Glenmark since October 1999 and is an executive member of the Board. With over 28 years of experience in the pharmaceutical field, she currently heads the Company’s Corporate Communications, Corporate Affairs, IT, Admin, HR and CSR functions. She had set up a pharmaceutical company where she served as the Managing Director from 1989 to 1999 before joining Glenmark.

Basic Compensation

Total Annual Compensation, INR 38,630,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR 4,310,000
Fiscal Year Total, INR 42,940,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Saldanha

161,620,000

V. S. Mani

21,140,000

Harish Kuber

2,750,000

Cherylann Pinto

42,940,000

Rajesh Desai

1,200,000

Blanche Saldanha

400,000
As Of  31 Mar 2018